

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.30305084 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.30305084 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.24309248 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.24309248 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.75911473 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.45738742 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 4.45738742 |
| 8 | lysine metabolic process (GO:0006553) | 4.40245805 |
| 9 | lysine catabolic process (GO:0006554) | 4.40245805 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.36529562 |
| 11 | aromatic amino acid family catabolic process (GO:0009074) | 4.33961583 |
| 12 | glyoxylate metabolic process (GO:0046487) | 4.26389314 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.24721691 |
| 14 | cysteine metabolic process (GO:0006534) | 4.17226493 |
| 15 | protein localization to endosome (GO:0036010) | 4.09511752 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 4.03477546 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.01004082 |
| 18 | kynurenine metabolic process (GO:0070189) | 3.99451028 |
| 19 | protein carboxylation (GO:0018214) | 3.89597610 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.89597610 |
| 21 | regulation of cholesterol homeostasis (GO:2000188) | 3.83661590 |
| 22 | plasma lipoprotein particle clearance (GO:0034381) | 3.79486452 |
| 23 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.68472714 |
| 24 | bile acid biosynthetic process (GO:0006699) | 3.62141214 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 3.61784171 |
| 26 | low-density lipoprotein particle clearance (GO:0034383) | 3.60196933 |
| 27 | complement activation, alternative pathway (GO:0006957) | 3.57832126 |
| 28 | pinocytosis (GO:0006907) | 3.57457337 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 3.57415915 |
| 30 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.57013795 |
| 31 | negative regulation of cholesterol transport (GO:0032375) | 3.56045297 |
| 32 | negative regulation of sterol transport (GO:0032372) | 3.56045297 |
| 33 | ethanol oxidation (GO:0006069) | 3.53811243 |
| 34 | urea metabolic process (GO:0019627) | 3.53320227 |
| 35 | urea cycle (GO:0000050) | 3.53320227 |
| 36 | tryptophan catabolic process (GO:0006569) | 3.51388502 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.51388502 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.51388502 |
| 39 | homocysteine metabolic process (GO:0050667) | 3.51355520 |
| 40 | high-density lipoprotein particle remodeling (GO:0034375) | 3.50255372 |
| 41 | regulation of fibrinolysis (GO:0051917) | 3.44121279 |
| 42 | fatty acid beta-oxidation (GO:0006635) | 3.43257176 |
| 43 | cellular modified amino acid catabolic process (GO:0042219) | 3.39082734 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 3.35753131 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 3.34093311 |
| 46 | 2-oxoglutarate metabolic process (GO:0006103) | 3.33129205 |
| 47 | protein retention in ER lumen (GO:0006621) | 3.32637568 |
| 48 | regulation of protein activation cascade (GO:2000257) | 3.32106577 |
| 49 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.31630408 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 3.30835051 |
| 51 | tryptophan metabolic process (GO:0006568) | 3.30358934 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 3.29317231 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.28733846 |
| 54 | regulation of early endosome to late endosome transport (GO:2000641) | 3.28226773 |
| 55 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.27978205 |
| 56 | fatty acid oxidation (GO:0019395) | 3.25842475 |
| 57 | 4-hydroxyproline metabolic process (GO:0019471) | 3.25086560 |
| 58 | barbed-end actin filament capping (GO:0051016) | 3.24596867 |
| 59 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22561922 |
| 60 | mannose metabolic process (GO:0006013) | 3.22238733 |
| 61 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.21703993 |
| 62 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.21479632 |
| 63 | nitrogen cycle metabolic process (GO:0071941) | 3.20727503 |
| 64 | bile acid metabolic process (GO:0008206) | 3.19831742 |
| 65 | lipid oxidation (GO:0034440) | 3.18393045 |
| 66 | pentose-phosphate shunt (GO:0006098) | 3.18005037 |
| 67 | regulation of complement activation (GO:0030449) | 3.17119743 |
| 68 | reverse cholesterol transport (GO:0043691) | 3.16720283 |
| 69 | valine metabolic process (GO:0006573) | 3.14121410 |
| 70 | serine family amino acid catabolic process (GO:0009071) | 3.12994723 |
| 71 | fatty acid catabolic process (GO:0009062) | 3.11564881 |
| 72 | maternal placenta development (GO:0001893) | 3.10776758 |
| 73 | response to mercury ion (GO:0046689) | 3.10684450 |
| 74 | alpha-amino acid catabolic process (GO:1901606) | 3.09176449 |
| 75 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08143170 |
| 76 | aromatic amino acid family metabolic process (GO:0009072) | 3.07351281 |
| 77 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.06680314 |
| 78 | NADPH regeneration (GO:0006740) | 3.05615880 |
| 79 | response to laminar fluid shear stress (GO:0034616) | 3.05016858 |
| 80 | regulation of cholesterol esterification (GO:0010872) | 3.04707677 |
| 81 | triglyceride homeostasis (GO:0070328) | 3.04095625 |
| 82 | acylglycerol homeostasis (GO:0055090) | 3.04095625 |
| 83 | cholesterol homeostasis (GO:0042632) | 3.04012116 |
| 84 | phospholipid efflux (GO:0033700) | 3.03513230 |
| 85 | response to peptidoglycan (GO:0032494) | 3.03238886 |
| 86 | sterol homeostasis (GO:0055092) | 3.02724207 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 3.01139815 |
| 88 | modulation by symbiont of host cellular process (GO:0044068) | 3.00594362 |
| 89 | plasma lipoprotein particle remodeling (GO:0034369) | 3.00473175 |
| 90 | protein-lipid complex remodeling (GO:0034368) | 3.00473175 |
| 91 | macromolecular complex remodeling (GO:0034367) | 3.00473175 |
| 92 | NIK/NF-kappaB signaling (GO:0038061) | 3.00389972 |
| 93 | protein-lipid complex assembly (GO:0065005) | 2.99391583 |
| 94 | apoptotic process involved in morphogenesis (GO:0060561) | 2.99107222 |
| 95 | regulation of cholesterol metabolic process (GO:0090181) | 2.98991351 |
| 96 | cellular amino acid catabolic process (GO:0009063) | 2.98256855 |
| 97 | glutamate metabolic process (GO:0006536) | 2.97361087 |
| 98 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.95400536 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 2.95172900 |
| 100 | glycosphingolipid catabolic process (GO:0046479) | 2.95054137 |
| 101 | ethanol metabolic process (GO:0006067) | 2.94977864 |
| 102 | serine family amino acid metabolic process (GO:0009069) | 2.93512487 |
| 103 | ketone body metabolic process (GO:1902224) | 2.92263843 |
| 104 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.91887601 |
| 105 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.91887601 |
| 106 | tyrosine metabolic process (GO:0006570) | 2.91295827 |
| 107 | phospholipid homeostasis (GO:0055091) | 2.89576346 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.88632462 |
| 109 | drug catabolic process (GO:0042737) | 2.88605705 |
| 110 | regulation of cholesterol storage (GO:0010885) | 2.88333654 |
| 111 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.88050475 |
| 112 | cholesterol efflux (GO:0033344) | 2.87711146 |
| 113 | fibrinolysis (GO:0042730) | 2.86248960 |
| 114 | plasma lipoprotein particle assembly (GO:0034377) | 2.86115574 |
| 115 | glycine metabolic process (GO:0006544) | 2.85521354 |
| 116 | serine family amino acid biosynthetic process (GO:0009070) | 2.85085534 |
| 117 | proline biosynthetic process (GO:0006561) | 2.83446524 |
| 118 | drug transmembrane transport (GO:0006855) | 2.83118105 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 2.82638355 |
| 120 | lipoprotein metabolic process (GO:0042157) | 2.81836346 |
| 121 | tricarboxylic acid metabolic process (GO:0072350) | 2.80393644 |
| 122 | apoptotic cell clearance (GO:0043277) | 2.80066744 |
| 123 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.78529044 |
| 124 | organic acid catabolic process (GO:0016054) | 2.78380526 |
| 125 | carboxylic acid catabolic process (GO:0046395) | 2.78380526 |
| 126 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.78282381 |
| 127 | adherens junction assembly (GO:0034333) | 2.77254224 |
| 128 | activation of Rac GTPase activity (GO:0032863) | 2.76371795 |
| 129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75836795 |
| 130 | stress fiber assembly (GO:0043149) | 2.75744870 |
| 131 | cell-substrate adherens junction assembly (GO:0007045) | 2.74926321 |
| 132 | focal adhesion assembly (GO:0048041) | 2.74926321 |
| 133 | negative regulation of cell size (GO:0045792) | 2.74732939 |
| 134 | embryonic process involved in female pregnancy (GO:0060136) | 2.70763995 |
| 135 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.67884507 |
| 136 | epithelial cell-cell adhesion (GO:0090136) | 2.65043609 |
| 137 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.64954186 |
| 138 | basement membrane organization (GO:0071711) | 2.64252808 |
| 139 | modulation by virus of host process (GO:0019054) | 2.62574308 |
| 140 | regulation of extracellular matrix disassembly (GO:0010715) | 2.62334153 |
| 141 | glucose 6-phosphate metabolic process (GO:0051156) | 2.61890388 |
| 142 | glycolipid catabolic process (GO:0019377) | 2.61762780 |
| 143 | glucose catabolic process (GO:0006007) | 2.61708175 |
| 144 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.59085206 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.56800822 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.56800822 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.56800822 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.56800822 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56800822 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.56800822 |
| 151 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.53684944 |
| 152 | surfactant homeostasis (GO:0043129) | 2.48573968 |
| 153 | negative regulation of fatty acid transport (GO:2000192) | 2.48440796 |
| 154 | regulation of defense response to virus by virus (GO:0050690) | 2.46091330 |
| 155 | cell-substrate junction assembly (GO:0007044) | 2.45987925 |
| 156 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.45717413 |
| 157 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.42708804 |
| 158 | response to muramyl dipeptide (GO:0032495) | 2.42231322 |
| 159 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42109959 |
| 160 | skin morphogenesis (GO:0043589) | 2.41888827 |
| 161 | detection of other organism (GO:0098543) | 2.40880396 |
| 162 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.40351365 |
| 163 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.36965084 |
| 164 | detection of bacterium (GO:0016045) | 2.36235939 |
| 165 | positive regulation of nuclease activity (GO:0032075) | 2.33234452 |
| 166 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.31493298 |
| 167 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.31327942 |
| 168 | semaphorin-plexin signaling pathway (GO:0071526) | 2.30884114 |
| 169 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.30570697 |
| 170 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.30245381 |
| 171 | positive regulation of extracellular matrix organization (GO:1903055) | 2.30076485 |
| 172 | regulation of superoxide anion generation (GO:0032928) | 2.29816946 |
| 173 | activation of MAPKKK activity (GO:0000185) | 2.29789175 |
| 174 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.29032302 |
| 175 | modulation by virus of host morphology or physiology (GO:0019048) | 2.28240683 |
| 176 | cellular response to virus (GO:0098586) | 2.25733658 |
| 177 | hyaluronan catabolic process (GO:0030214) | 2.25552841 |
| 178 | desmosome organization (GO:0002934) | 2.23255770 |
| 179 | positive regulation of receptor recycling (GO:0001921) | 2.23177499 |
| 180 | regulation of leukocyte degranulation (GO:0043300) | 2.21829473 |
| 181 | negative regulation of viral release from host cell (GO:1902187) | 2.20524061 |
| 182 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.20178780 |
| 183 | RNA stabilization (GO:0043489) | 2.19990213 |
| 184 | mRNA stabilization (GO:0048255) | 2.19990213 |
| 185 | embryo implantation (GO:0007566) | 2.19367946 |
| 186 | response to thyroid hormone (GO:0097066) | 2.16526923 |
| 187 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.15135657 |
| 188 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.15132509 |
| 189 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.14804590 |
| 190 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.14418137 |
| 191 | regulation of extracellular matrix organization (GO:1903053) | 2.13967294 |
| 192 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.11646408 |
| 193 | regulation of lipid kinase activity (GO:0043550) | 2.11506764 |
| 194 | regulation of nuclease activity (GO:0032069) | 2.10831719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.88197407 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98001850 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84001489 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.62316891 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.00145877 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.84622031 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.79824674 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.73974270 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.57379958 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41518753 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.39656905 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36023936 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35728748 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27984099 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.22287960 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94830887 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88764549 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.87450025 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84956555 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81282563 |
| 21 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.73946800 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.73775018 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65987740 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65037495 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63806054 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63176475 |
| 27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61435519 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60990617 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59947994 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59074103 |
| 31 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.56072350 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55147313 |
| 33 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49620736 |
| 34 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47672628 |
| 35 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47655227 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.46757582 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45097423 |
| 38 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37614884 |
| 39 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37201125 |
| 40 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.37095381 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36994680 |
| 42 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36929334 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36812706 |
| 44 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36723705 |
| 45 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36371388 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34502949 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.33955865 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32932610 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32520980 |
| 50 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.32436065 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31781422 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30466104 |
| 53 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27767986 |
| 54 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.26518473 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26320312 |
| 56 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25085793 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24660967 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24660967 |
| 59 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24402312 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.24345536 |
| 61 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.23846474 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23701424 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22910055 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20204812 |
| 65 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19728685 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18879911 |
| 67 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18432084 |
| 68 | * MAF_26560356_Chip-Seq_TH2_Human | 1.18106610 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16716717 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16215610 |
| 71 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15734722 |
| 72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.15413292 |
| 73 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15136038 |
| 74 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.14769186 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14440329 |
| 76 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13826124 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13309105 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13028136 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12811993 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12430326 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12371811 |
| 82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.10904957 |
| 83 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.10663503 |
| 84 | MAF_26560356_Chip-Seq_TH1_Human | 1.09677375 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09245888 |
| 86 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08192069 |
| 87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06857596 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06753551 |
| 89 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06513950 |
| 90 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05775490 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05762454 |
| 92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04837385 |
| 93 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04767160 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.04601652 |
| 95 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04249147 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03359661 |
| 97 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.02736378 |
| 98 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01992971 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01289844 |
| 100 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01139310 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01071012 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00486777 |
| 103 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00071335 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99314400 |
| 105 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99170672 |
| 106 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98586428 |
| 107 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97532652 |
| 108 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.97124152 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.96889047 |
| 110 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.96267672 |
| 111 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95766028 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95076339 |
| 113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94788906 |
| 114 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94112688 |
| 115 | P68_20966046_ChIP-Seq_HELA_Human | 0.93243748 |
| 116 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92299640 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92219489 |
| 118 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91615236 |
| 119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91165952 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89088305 |
| 121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89034011 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88474050 |
| 123 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88388634 |
| 124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87514188 |
| 125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87298270 |
| 126 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.86873335 |
| 127 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.86510029 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85469430 |
| 129 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85441910 |
| 130 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.83574121 |
| 131 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83126890 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83105684 |
| 133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83036343 |
| 134 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.82999063 |
| 135 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82536401 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82131686 |
| 137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82033676 |
| 138 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.80917538 |
| 139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80239424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.27456887 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.00486050 |
| 3 | MP0009840_abnormal_foam_cell | 3.78241080 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.61792018 |
| 5 | MP0005365_abnormal_bile_salt | 3.59111119 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.39507690 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.01487856 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.76077940 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.67225201 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.52716948 |
| 11 | MP0003252_abnormal_bile_duct | 2.52118350 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.42678198 |
| 13 | MP0005083_abnormal_biliary_tract | 2.37832943 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.17951217 |
| 15 | MP0005332_abnormal_amino_acid | 2.12887009 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.09555455 |
| 17 | MP0003195_calcinosis | 2.08374779 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.04908892 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.01143253 |
| 20 | MP0008260_abnormal_autophagy | 2.01001817 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.98437848 |
| 22 | MP0000858_altered_metastatic_potential | 1.77118689 |
| 23 | MP0004858_abnormal_nervous_system | 1.73107888 |
| 24 | MP0000609_abnormal_liver_physiology | 1.72148900 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.65341334 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.61440929 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.58620459 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.54235469 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.49100894 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.48137529 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 1.45831638 |
| 32 | MP0005409_darkened_coat_color | 1.42468014 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.41618861 |
| 34 | MP0005501_abnormal_skin_physiology | 1.40923231 |
| 35 | MP0003303_peritoneal_inflammation | 1.38651409 |
| 36 | MP0005451_abnormal_body_composition | 1.37600798 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.36529787 |
| 38 | MP0000604_amyloidosis | 1.34966087 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.34833729 |
| 40 | MP0004019_abnormal_vitamin_homeostasis | 1.33098865 |
| 41 | MP0002419_abnormal_innate_immunity | 1.32538904 |
| 42 | MP0010234_abnormal_vibrissa_follicle | 1.31677377 |
| 43 | MP0004130_abnormal_muscle_cell | 1.31543013 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.30420167 |
| 45 | MP0005025_abnormal_response_to | 1.30077252 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.27064468 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.26138795 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.21021640 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20798106 |
| 50 | MP0004272_abnormal_basement_membrane | 1.20109783 |
| 51 | MP0000685_abnormal_immune_system | 1.17157298 |
| 52 | MP0001216_abnormal_epidermal_layer | 1.13231308 |
| 53 | MP0000490_abnormal_crypts_of | 1.12152168 |
| 54 | MP0004233_abnormal_muscle_weight | 1.11485707 |
| 55 | MP0005275_abnormal_skin_tensile | 1.11086494 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.11055389 |
| 57 | MP0001958_emphysema | 1.10468628 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.08158278 |
| 59 | MP0000678_abnormal_parathyroid_gland | 1.07609962 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.06442288 |
| 61 | MP0004510_myositis | 1.05919333 |
| 62 | MP0000598_abnormal_liver_morphology | 1.05672737 |
| 63 | MP0003329_amyloid_beta_deposits | 1.05266051 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 1.04339098 |
| 65 | MP0005023_abnormal_wound_healing | 1.04221028 |
| 66 | MP0004084_abnormal_cardiac_muscle | 1.03799547 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 1.03177481 |
| 68 | MP0001790_abnormal_immune_system | 1.02365052 |
| 69 | MP0005387_immune_system_phenotype | 1.02365052 |
| 70 | MP0001853_heart_inflammation | 1.00523037 |
| 71 | MP0003448_altered_tumor_morphology | 1.00358507 |
| 72 | MP0004381_abnormal_hair_follicle | 1.00135760 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 0.99439347 |
| 74 | MP0005375_adipose_tissue_phenotype | 0.98360162 |
| 75 | MP0006054_spinal_hemorrhage | 0.98314849 |
| 76 | MP0003690_abnormal_glial_cell | 0.97655815 |
| 77 | MP0005330_cardiomyopathy | 0.96790238 |
| 78 | MP0009785_altered_susceptibility_to | 0.96497412 |
| 79 | MP0002098_abnormal_vibrissa_morphology | 0.96388153 |
| 80 | MP0000537_abnormal_urethra_morphology | 0.95645678 |
| 81 | MP0002452_abnormal_antigen_presenting | 0.95411883 |
| 82 | MP0005670_abnormal_white_adipose | 0.94477105 |
| 83 | MP0004782_abnormal_surfactant_physiolog | 0.94446196 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.94186630 |
| 85 | MP0002796_impaired_skin_barrier | 0.93188741 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.91817966 |
| 87 | MP0001849_ear_inflammation | 0.91310897 |
| 88 | MP0001873_stomach_inflammation | 0.90970895 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.90498563 |
| 90 | MP0009931_abnormal_skin_appearance | 0.89134098 |
| 91 | MP0001756_abnormal_urination | 0.88795154 |
| 92 | MP0002396_abnormal_hematopoietic_system | 0.88765787 |
| 93 | MP0001819_abnormal_immune_cell | 0.87752133 |
| 94 | MP0002723_abnormal_immune_serum | 0.86920328 |
| 95 | MP0002420_abnormal_adaptive_immunity | 0.86739580 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.86726810 |
| 97 | MP0004947_skin_inflammation | 0.86335224 |
| 98 | MP0002971_abnormal_brown_adipose | 0.83448413 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.83029898 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.82989866 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.82400849 |
| 102 | MP0009384_cardiac_valve_regurgitation | 0.81292633 |
| 103 | MP0001800_abnormal_humoral_immune | 0.81086406 |
| 104 | MP0003724_increased_susceptibility_to | 0.81001393 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.80906113 |
| 106 | MP0000377_abnormal_hair_follicle | 0.80800532 |
| 107 | MP0000747_muscle_weakness | 0.80722461 |
| 108 | MP0004043_abnormal_pH_regulation | 0.80543303 |
| 109 | MP0003868_abnormal_feces_composition | 0.80503522 |
| 110 | MP0003828_pulmonary_edema | 0.80106126 |
| 111 | MP0010352_gastrointestinal_tract_polyps | 0.79924511 |
| 112 | MP0010630_abnormal_cardiac_muscle | 0.79180213 |
| 113 | MP0003186_abnormal_redox_activity | 0.78827855 |
| 114 | MP0002837_dystrophic_cardiac_calcinosis | 0.78745320 |
| 115 | MP0005621_abnormal_cell_physiology | 0.78356963 |
| 116 | MP0006082_CNS_inflammation | 0.77475869 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.77053548 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76910566 |
| 119 | MP0009763_increased_sensitivity_to | 0.76240570 |
| 120 | MP0008469_abnormal_protein_level | 0.75836021 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.75758033 |
| 122 | MP0002060_abnormal_skin_morphology | 0.75490206 |
| 123 | MP0003950_abnormal_plasma_membrane | 0.74731769 |
| 124 | MP0001915_intracranial_hemorrhage | 0.74024983 |
| 125 | MP0001851_eye_inflammation | 0.73808948 |
| 126 | MP0005390_skeleton_phenotype | 0.73501695 |
| 127 | MP0000477_abnormal_intestine_morphology | 0.73198382 |
| 128 | MP0004036_abnormal_muscle_relaxation | 0.72736978 |
| 129 | MP0003279_aneurysm | 0.71924293 |
| 130 | MP0000343_altered_response_to | 0.71826072 |
| 131 | MP0003436_decreased_susceptibility_to | 0.71293493 |
| 132 | MP0002398_abnormal_bone_marrow | 0.71143226 |
| 133 | MP0009053_abnormal_anal_canal | 0.71120087 |
| 134 | MP0003075_altered_response_to | 0.70537279 |
| 135 | MP0002405_respiratory_system_inflammati | 0.69947630 |
| 136 | MP0000716_abnormal_immune_system | 0.69694166 |
| 137 | MP0002269_muscular_atrophy | 0.67950260 |
| 138 | MP0000249_abnormal_blood_vessel | 0.66725813 |
| 139 | MP0000920_abnormal_myelination | 0.65577607 |
| 140 | MP0005636_abnormal_mineral_homeostasis | 0.65319174 |
| 141 | MP0004264_abnormal_extraembryonic_tissu | 0.65183389 |
| 142 | MP0001533_abnormal_skeleton_physiology | 0.64756494 |
| 143 | MP0000750_abnormal_muscle_regeneration | 0.64038690 |
| 144 | MP0003091_abnormal_cell_migration | 0.63534553 |
| 145 | MP0000467_abnormal_esophagus_morphology | 0.63256749 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.63143128 |
| 147 | MP0001243_abnormal_dermal_layer | 0.62584788 |
| 148 | MP0005408_hypopigmentation | 0.61595029 |
| 149 | MP0008961_abnormal_basal_metabolism | 0.61102472 |
| 150 | MP0005165_increased_susceptibility_to | 0.60725704 |
| 151 | MP0000003_abnormal_adipose_tissue | 0.59996695 |
| 152 | MP0001544_abnormal_cardiovascular_syste | 0.58653155 |
| 153 | MP0005385_cardiovascular_system_phenoty | 0.58653155 |
| 154 | MP0002254_reproductive_system_inflammat | 0.58636662 |
| 155 | MP0002128_abnormal_blood_circulation | 0.58340640 |
| 156 | MP0000767_abnormal_smooth_muscle | 0.57944420 |
| 157 | MP0001661_extended_life_span | 0.57925241 |
| 158 | MP0000465_gastrointestinal_hemorrhage | 0.57644388 |
| 159 | MP0009278_abnormal_bone_marrow | 0.57225559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.14318301 |
| 2 | Xanthomatosis (HP:0000991) | 4.60960961 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.42710030 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.20829277 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.83731602 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.57112937 |
| 7 | Complement deficiency (HP:0004431) | 3.46675397 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.35798364 |
| 9 | Hyperammonemia (HP:0001987) | 3.28662814 |
| 10 | Ketosis (HP:0001946) | 3.25799016 |
| 11 | Hypoglycemic coma (HP:0001325) | 3.16966007 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.10158052 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.08924599 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05802031 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05802031 |
| 16 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05802031 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.92785956 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 2.88627139 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88627139 |
| 20 | Hyperacusis (HP:0010780) | 2.84164130 |
| 21 | Hyperglycinuria (HP:0003108) | 2.82466267 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.80484662 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.79217228 |
| 24 | Asymmetry of the thorax (HP:0001555) | 2.75492959 |
| 25 | Myocardial infarction (HP:0001658) | 2.74719401 |
| 26 | Ketoacidosis (HP:0001993) | 2.73912510 |
| 27 | Abnormality of complement system (HP:0005339) | 2.73587558 |
| 28 | Flat acetabular roof (HP:0003180) | 2.70997178 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70184809 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 2.70066043 |
| 31 | Hypolipoproteinemia (HP:0010981) | 2.68679978 |
| 32 | Epidermoid cyst (HP:0200040) | 2.62832966 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.61983132 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.61888006 |
| 35 | Thin bony cortex (HP:0002753) | 2.57683340 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.57295637 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 2.48993603 |
| 38 | Premature rupture of membranes (HP:0001788) | 2.46833961 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.45679319 |
| 40 | Esophageal varix (HP:0002040) | 2.45202681 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.44754082 |
| 42 | Joint hemorrhage (HP:0005261) | 2.41344387 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.39774809 |
| 44 | Spastic diplegia (HP:0001264) | 2.39768855 |
| 45 | Peritonitis (HP:0002586) | 2.39032002 |
| 46 | Hyperglycinemia (HP:0002154) | 2.37498269 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.37335152 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.35339740 |
| 49 | Axonal loss (HP:0003447) | 2.34936600 |
| 50 | Fat malabsorption (HP:0002630) | 2.33052373 |
| 51 | Polycythemia (HP:0001901) | 2.32323877 |
| 52 | Loss of speech (HP:0002371) | 2.32065737 |
| 53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30283907 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.28466722 |
| 55 | Gout (HP:0001997) | 2.27811745 |
| 56 | Skin nodule (HP:0200036) | 2.25312482 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.24511743 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.24283246 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.24264344 |
| 60 | J-shaped sella turcica (HP:0002680) | 2.22872341 |
| 61 | Hyperparathyroidism (HP:0000843) | 2.22526319 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.22195615 |
| 63 | Cerebral aneurysm (HP:0004944) | 2.21585048 |
| 64 | Myoglobinuria (HP:0002913) | 2.20332452 |
| 65 | Back pain (HP:0003418) | 2.19651832 |
| 66 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.19465515 |
| 67 | Asymmetric septal hypertrophy (HP:0001670) | 2.18586085 |
| 68 | Broad face (HP:0000283) | 2.17789982 |
| 69 | Vascular calcification (HP:0004934) | 2.17595837 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.17373523 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17373523 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.14143121 |
| 73 | Abnormal cartilage morphology (HP:0002763) | 2.13473164 |
| 74 | Distal lower limb amyotrophy (HP:0008944) | 2.12242746 |
| 75 | Recurrent abscess formation (HP:0002722) | 2.11804092 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.11039652 |
| 77 | Abnormality of methionine metabolism (HP:0010901) | 2.09592768 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.09026112 |
| 79 | Bone pain (HP:0002653) | 2.06815164 |
| 80 | Polygenic inheritance (HP:0010982) | 2.06350303 |
| 81 | Broad metatarsal (HP:0001783) | 2.06273631 |
| 82 | Abnormality of the thoracic spine (HP:0100711) | 2.05836864 |
| 83 | Vacuolated lymphocytes (HP:0001922) | 2.05708448 |
| 84 | Cellulitis (HP:0100658) | 2.04698991 |
| 85 | Late onset (HP:0003584) | 2.04002425 |
| 86 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03408865 |
| 87 | Lymphangioma (HP:0100764) | 2.03089996 |
| 88 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02506936 |
| 89 | Osteolytic defects of the hand bones (HP:0009699) | 2.02506936 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.01583233 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.01583233 |
| 92 | Hyporeflexia of lower limbs (HP:0002600) | 2.01408048 |
| 93 | Malnutrition (HP:0004395) | 1.99718181 |
| 94 | Cervical subluxation (HP:0003308) | 1.99475743 |
| 95 | Spinal cord lesions (HP:0100561) | 1.99028422 |
| 96 | Syringomyelia (HP:0003396) | 1.99028422 |
| 97 | Hepatocellular carcinoma (HP:0001402) | 1.98891007 |
| 98 | Mucopolysacchariduria (HP:0008155) | 1.98787241 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.98787241 |
| 100 | Mitral stenosis (HP:0001718) | 1.97521842 |
| 101 | Cholelithiasis (HP:0001081) | 1.96165432 |
| 102 | Glomerulonephritis (HP:0000099) | 1.94499996 |
| 103 | Visceral angiomatosis (HP:0100761) | 1.92798327 |
| 104 | Colitis (HP:0002583) | 1.92795064 |
| 105 | Recurrent bacterial skin infections (HP:0005406) | 1.91828279 |
| 106 | Ileus (HP:0002595) | 1.91559923 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90810357 |
| 108 | Abnormal gallbladder morphology (HP:0012437) | 1.89612848 |
| 109 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.88785217 |
| 110 | Amyloidosis (HP:0011034) | 1.87801194 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.86476696 |
| 112 | Ulnar bowing (HP:0003031) | 1.86334534 |
| 113 | Increased connective tissue (HP:0009025) | 1.86222409 |
| 114 | Achilles tendon contracture (HP:0001771) | 1.85983228 |
| 115 | Thoracic kyphosis (HP:0002942) | 1.83819582 |
| 116 | Neurofibrillary tangles (HP:0002185) | 1.83356503 |
| 117 | Abnormality of iron homeostasis (HP:0011031) | 1.83176181 |
| 118 | Short nail (HP:0001799) | 1.82337380 |
| 119 | Aneurysm (HP:0002617) | 1.81180659 |
| 120 | Turricephaly (HP:0000262) | 1.80282806 |
| 121 | Cholecystitis (HP:0001082) | 1.80217151 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 1.80217151 |
| 123 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.80163628 |
| 124 | Purpura (HP:0000979) | 1.80089579 |
| 125 | Upper limb amyotrophy (HP:0009129) | 1.80026279 |
| 126 | Distal upper limb amyotrophy (HP:0007149) | 1.80026279 |
| 127 | Hyperbilirubinemia (HP:0002904) | 1.79866764 |
| 128 | Increased serum ferritin (HP:0003281) | 1.79542024 |
| 129 | Disproportionate tall stature (HP:0001519) | 1.79344709 |
| 130 | Blue sclerae (HP:0000592) | 1.79129723 |
| 131 | Muscle fiber splitting (HP:0003555) | 1.78775665 |
| 132 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78528857 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 1.78515901 |
| 134 | Hemangiomatosis (HP:0007461) | 1.78423215 |
| 135 | Nephritis (HP:0000123) | 1.77290905 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77067649 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77067649 |
| 138 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77067649 |
| 139 | Long palpebral fissure (HP:0000637) | 1.75945718 |
| 140 | Trismus (HP:0000211) | 1.75166798 |
| 141 | Exercise-induced muscle cramps (HP:0003710) | 1.75022920 |
| 142 | Gingivitis (HP:0000230) | 1.73404239 |
| 143 | Pathologic fracture (HP:0002756) | 1.73266088 |
| 144 | Multiple lipomas (HP:0001012) | 1.72721270 |
| 145 | Nuclear cataract (HP:0100018) | 1.71748069 |
| 146 | Abdominal distention (HP:0003270) | 1.71316541 |
| 147 | Increased IgE level (HP:0003212) | 1.69160556 |
| 148 | Fragile skin (HP:0001030) | 1.67533812 |
| 149 | Mitral regurgitation (HP:0001653) | 1.66586266 |
| 150 | Hypercortisolism (HP:0001578) | 1.65991699 |
| 151 | Arterial tortuosity (HP:0005116) | 1.65594673 |
| 152 | Dilatation of the ascending aorta (HP:0005111) | 1.63804102 |
| 153 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.63038112 |
| 154 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.62934480 |
| 155 | Abnormal ossification of hand bones (HP:0005921) | 1.61312639 |
| 156 | Micronodular cirrhosis (HP:0001413) | 1.61031831 |
| 157 | Neuronal loss in central nervous system (HP:0002529) | 1.59827422 |
| 158 | Deformed sella turcica (HP:0002681) | 1.59657008 |
| 159 | Gastrointestinal inflammation (HP:0004386) | 1.57702208 |
| 160 | Cupped ribs (HP:0000887) | 1.57002982 |
| 161 | Ankyloglossia (HP:0010296) | 1.56096603 |
| 162 | Insomnia (HP:0100785) | 1.55577226 |
| 163 | Abnormality of carpal bone ossification (HP:0006257) | 1.55187104 |
| 164 | Metaphyseal cupping (HP:0003021) | 1.54020929 |
| 165 | Spinal cord compression (HP:0002176) | 1.53204263 |
| 166 | Biconcave vertebral bodies (HP:0004586) | 1.52039705 |
| 167 | Vascular tortuosity (HP:0004948) | 1.51081376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.01172031 |
| 2 | PKN2 | 3.94397612 |
| 3 | ERN1 | 3.86790889 |
| 4 | PRPF4B | 3.48015109 |
| 5 | SMG1 | 3.15611396 |
| 6 | IRAK3 | 3.07602299 |
| 7 | BCKDK | 2.94346526 |
| 8 | EPHB1 | 2.85137984 |
| 9 | NME2 | 2.63233750 |
| 10 | SIK1 | 2.53065269 |
| 11 | TTN | 2.47760034 |
| 12 | EEF2K | 2.21069230 |
| 13 | PTK6 | 2.20308937 |
| 14 | FGFR4 | 2.13520742 |
| 15 | MAP3K10 | 2.03746454 |
| 16 | RIPK1 | 1.90622503 |
| 17 | LRRK2 | 1.66654246 |
| 18 | LATS1 | 1.58924832 |
| 19 | BMX | 1.54213767 |
| 20 | MET | 1.49753808 |
| 21 | TAOK2 | 1.46972478 |
| 22 | ICK | 1.46892299 |
| 23 | PDGFRA | 1.45075824 |
| 24 | CDK12 | 1.43489121 |
| 25 | TGFBR2 | 1.40368947 |
| 26 | MAP3K13 | 1.37450859 |
| 27 | PAK4 | 1.33335177 |
| 28 | MAP3K14 | 1.20350621 |
| 29 | WNK4 | 1.18819187 |
| 30 | IRAK4 | 1.18556520 |
| 31 | ARAF | 1.16167254 |
| 32 | KDR | 1.15461619 |
| 33 | SIK3 | 1.14713476 |
| 34 | STK10 | 1.12470286 |
| 35 | DDR2 | 1.11128504 |
| 36 | PTK2 | 1.10862653 |
| 37 | STK39 | 1.10714682 |
| 38 | MAP2K2 | 1.10074040 |
| 39 | KSR2 | 1.08884627 |
| 40 | FLT3 | 1.06852474 |
| 41 | MAP4K1 | 1.06107104 |
| 42 | MST1R | 1.06066794 |
| 43 | TBK1 | 1.05446549 |
| 44 | TYK2 | 1.04633005 |
| 45 | RPS6KB2 | 1.04233251 |
| 46 | RIPK4 | 1.03263741 |
| 47 | MAP2K3 | 0.98020836 |
| 48 | TAOK3 | 0.98006825 |
| 49 | TIE1 | 0.96306991 |
| 50 | CSK | 0.94238826 |
| 51 | CDC42BPA | 0.94055680 |
| 52 | PAK2 | 0.93605892 |
| 53 | CAMK1D | 0.87956824 |
| 54 | IRAK2 | 0.86443338 |
| 55 | JAK2 | 0.83873980 |
| 56 | GRK6 | 0.82818371 |
| 57 | PRKD1 | 0.82487962 |
| 58 | TESK2 | 0.82466054 |
| 59 | LATS2 | 0.82197440 |
| 60 | RET | 0.81498020 |
| 61 | NEK9 | 0.80930241 |
| 62 | MAP3K7 | 0.80612012 |
| 63 | FGFR2 | 0.80135414 |
| 64 | EPHA2 | 0.78713048 |
| 65 | DMPK | 0.77408856 |
| 66 | JAK1 | 0.76866107 |
| 67 | DYRK1B | 0.76472279 |
| 68 | CDK6 | 0.76103675 |
| 69 | LMTK2 | 0.74790795 |
| 70 | ILK | 0.74377346 |
| 71 | RPS6KA2 | 0.73786630 |
| 72 | MTOR | 0.72852446 |
| 73 | PRKD2 | 0.72007098 |
| 74 | MOS | 0.71854280 |
| 75 | MAPK11 | 0.71666556 |
| 76 | MAP3K3 | 0.71557464 |
| 77 | MARK2 | 0.70431743 |
| 78 | JAK3 | 0.69106489 |
| 79 | MAP3K8 | 0.68881078 |
| 80 | PDGFRB | 0.68875929 |
| 81 | PRKG2 | 0.68695485 |
| 82 | PIM2 | 0.66998407 |
| 83 | TYRO3 | 0.66691045 |
| 84 | PDPK1 | 0.66650338 |
| 85 | MAP3K11 | 0.66036049 |
| 86 | EPHB2 | 0.65975950 |
| 87 | TAOK1 | 0.65743510 |
| 88 | RPS6KC1 | 0.65665735 |
| 89 | RPS6KL1 | 0.65665735 |
| 90 | CSF1R | 0.64663762 |
| 91 | ALK | 0.63573515 |
| 92 | ERBB4 | 0.63036918 |
| 93 | PAK3 | 0.62091091 |
| 94 | GSK3A | 0.61173823 |
| 95 | PRKD3 | 0.59526878 |
| 96 | CDK7 | 0.58939689 |
| 97 | BRAF | 0.55664787 |
| 98 | PRKAA2 | 0.55071166 |
| 99 | STK3 | 0.55008790 |
| 100 | MAP3K6 | 0.54446895 |
| 101 | PIK3CG | 0.53927300 |
| 102 | CAMK1G | 0.53539132 |
| 103 | HIPK2 | 0.51477677 |
| 104 | FGFR1 | 0.51407137 |
| 105 | ITK | 0.50708058 |
| 106 | EPHA3 | 0.50281945 |
| 107 | PRKCH | 0.48913999 |
| 108 | MAP3K1 | 0.47823616 |
| 109 | MAP2K1 | 0.47737610 |
| 110 | ZAP70 | 0.46817577 |
| 111 | ABL2 | 0.46715724 |
| 112 | OXSR1 | 0.46400246 |
| 113 | CDK4 | 0.46077464 |
| 114 | MAPKAPK2 | 0.45796790 |
| 115 | TRPM7 | 0.45353663 |
| 116 | FGFR3 | 0.45342393 |
| 117 | MAPKAPK3 | 0.44084100 |
| 118 | MAP3K2 | 0.43713693 |
| 119 | TESK1 | 0.43283683 |
| 120 | FGR | 0.42860175 |
| 121 | LIMK1 | 0.42120124 |
| 122 | SCYL2 | 0.41992323 |
| 123 | NTRK1 | 0.41778018 |
| 124 | FER | 0.40479195 |
| 125 | RPS6KA6 | 0.40106592 |
| 126 | HCK | 0.39439926 |
| 127 | IKBKE | 0.38963804 |
| 128 | PDK1 | 0.38639478 |
| 129 | ROCK2 | 0.38437484 |
| 130 | NEK1 | 0.38146215 |
| 131 | BTK | 0.37275245 |
| 132 | DAPK3 | 0.36574913 |
| 133 | BLK | 0.36390099 |
| 134 | ERBB2 | 0.36329361 |
| 135 | MELK | 0.36224009 |
| 136 | MATK | 0.34321922 |
| 137 | MAP3K9 | 0.32748104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.43844601 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05408670 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.94211172 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83778744 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.72973158 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54952978 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53892546 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36087329 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34794375 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33035373 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.11725259 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.10734735 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.06533515 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.05175500 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03082239 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.02984628 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99837304 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.98400297 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90269063 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.89824040 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.75617562 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.70484213 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.69985952 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67978815 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66406158 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61135781 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.60824595 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58671027 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53412709 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52382016 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49465862 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49411421 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.49396061 |
| 34 | Thyroid cancer_Homo sapiens_hsa05216 | 1.49116317 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47220837 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46821372 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46385515 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45358721 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.39826250 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37369977 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.36300838 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.33549073 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31504997 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30527429 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29642867 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29338073 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28896588 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26779666 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23411444 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19666630 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.19280955 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.19110223 |
| 53 | * Notch signaling pathway_Homo sapiens_hsa04330 | 1.18597412 |
| 54 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18467324 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18392251 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 1.11863442 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 1.10301826 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10157582 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07958773 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 1.07388612 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06914373 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.06061516 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 1.04926541 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04829482 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04624109 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01672567 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01289011 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96964053 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.96084730 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.95509252 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.95496249 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93928554 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93474660 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.92373926 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91135557 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90076799 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.89539393 |
| 78 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89090389 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.88840762 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.87694431 |
| 81 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87691363 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86868186 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.86181785 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.85780155 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85646651 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85360335 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.85090597 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84197810 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81440126 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81311730 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.81147584 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81064255 |
| 93 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80417582 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.80093445 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79936586 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79670978 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79409314 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79084605 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75883883 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74899515 |
| 101 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74642969 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73990158 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.73420544 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73000019 |
| 105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.72500303 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.72006287 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71445666 |
| 108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71186545 |
| 109 | Malaria_Homo sapiens_hsa05144 | 0.71018354 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70647747 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.69930702 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69461037 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69083306 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68391330 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68336563 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.68142082 |
| 117 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67925891 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66484411 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64841083 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.63119335 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62993032 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61458675 |
| 123 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61011832 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60217779 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55750506 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54928922 |
| 127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54717802 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53212884 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53181012 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52833084 |
| 131 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52588190 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.52563516 |
| 133 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50967444 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.47604009 |
| 135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47393330 |
| 136 | Amoebiasis_Homo sapiens_hsa05146 | 0.47111004 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.45431553 |
| 138 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42794667 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40965311 |
| 140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40744102 |
| 141 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40114012 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.39900929 |
| 143 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38694690 |
| 144 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38402474 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37913402 |
| 146 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37129512 |
| 147 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32609317 |
| 148 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31379097 |
| 149 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30441387 |
| 150 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.28922297 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28578853 |
| 152 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28408593 |
| 153 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27253144 |
| 154 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26742988 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26606622 |
| 156 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24441398 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19584363 |
| 158 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19140251 |
| 159 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18749870 |
| 160 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18671731 |
| 161 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16342464 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | 0.15731781 |
| 163 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15473009 |
| 164 | Adherens junction_Homo sapiens_hsa04520 | 0.14878221 |
| 165 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.14499039 |
| 166 | Tight junction_Homo sapiens_hsa04530 | 0.13264000 |

